Literature DB >> 33910829

Detection of Circulating Gastrointestinal Cancer Cells in Conditionally Reprogrammed Cell Culture.

Chun-Seok Yang1, In-Hwan Kim1, Hyun-Dong Chae1, Dae-Dong Kim2, Chang-Ho Jeon3.   

Abstract

BACKGROUND/AIM: The aim of this study was to detect circulating tumor cells (CTC) in the peripheral blood of gastrointestinal cancer patients using conditionally reprogrammed cell (CRC) culture.
MATERIALS AND METHODS: We confirmed the sensitivity of the CRC culture method. Five ml of blood were obtained from 81 cancer patients (56 colorectal and 25 gastric). The collected mononuclear cells were cultured for 4 weeks in the CRC condition. Finally, cultured cells were characterized by RT-PCR for the expression of hTERT and MAGE A1-6 mRNA.
RESULTS: The CRC method had a CTC detection limit of 6 cells for gastric cancer cells. After culture of 81 blood specimens, 38 formed visible cells, including 5 colonies. Among the 38 cells, 13 were hTERT positive and 4 were MAGE A1-6 positive. The final CTC detection rate was 16.0%.
CONCLUSION: The CRC culture may potentially be used to evaluate the metastatic cancer cells in the circulation. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Blood; MAGE; culture; hTERT; neoplasm; reverse transcription

Mesh:

Substances:

Year:  2021        PMID: 33910829      PMCID: PMC8193337          DOI: 10.21873/invivo.12404

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  30 in total

Review 1.  Circulating cell-free DNA for non-invasive cancer management.

Authors:  Caitlin M Stewart; Dana W Y Tsui
Journal:  Cancer Genet       Date:  2018-03-11

2.  Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells.

Authors:  Frank A Suprynowicz; Geeta Upadhyay; Ewa Krawczyk; Sarah C Kramer; Jess D Hebert; Xuefeng Liu; Hang Yuan; Chaitra Cheluvaraju; Phillip W Clapp; Richard C Boucher; Christopher M Kamonjoh; Scott H Randell; Richard Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

3.  Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.

Authors:  Jussuf T Kaifi; Miriam Kunkel; David T Dicker; Jamal Joude; Joshua E Allen; Avisnata Das; Junjia Zhu; Zhaohai Yang; Nabeel E Sarwani; Guangfu Li; Kevin F Staveley-O'Carroll; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

4.  ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells.

Authors:  Xuefeng Liu; Virginie Ory; Sandra Chapman; Hang Yuan; Chris Albanese; Bhaskar Kallakury; Olga A Timofeeva; Caitlin Nealon; Aleksandra Dakic; Vera Simic; Bassem R Haddad; Johng S Rhim; Anatoly Dritschilo; Anna Riegel; Alison McBride; Richard Schlegel
Journal:  Am J Pathol       Date:  2011-12-18       Impact factor: 4.307

Review 5.  Circulating tumor cell technologies.

Authors:  Meghaan M Ferreira; Vishnu C Ramani; Stefanie S Jeffrey
Journal:  Mol Oncol       Date:  2016-01-28       Impact factor: 6.603

6.  Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation.

Authors:  Vladimir Bobek; Robert Gurlich; Petra Eliasova; Katarina Kolostova
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

7.  Detection of isolated tumour cells in the blood and bone marrow of patients with gastric cancer by combined sorting, isolation and determination of MAGE-1, -2 mRNA expression.

Authors:  Rafal Szatanek; Grazyna Drabik; Jaroslaw Baran; Piotr Kolodziejczyk; Jan Kulig; Jerzy Stachura; Marek Zembala
Journal:  Oncol Rep       Date:  2008-04       Impact factor: 3.906

8.  Detection and cultivation of circulating tumor cells in gastric cancer.

Authors:  Katarina Kolostova; Rafal Matkowski; Robert Gürlich; Krzysztof Grabowski; Katarzyna Soter; Robert Lischke; Jan Schützner; Vladimir Bobek
Journal:  Cytotechnology       Date:  2015-04-11       Impact factor: 2.058

9.  Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture.

Authors:  Fanny Grillet; Elsa Bayet; Olivia Villeronce; Luke Zappia; Ebba Louise Lagerqvist; Sebastian Lunke; Emmanuelle Charafe-Jauffret; Kym Pham; Christina Molck; Nathalie Rolland; Jean François Bourgaux; Michel Prudhomme; Claire Philippe; Sophie Bravo; Jean Christophe Boyer; Lucile Canterel-Thouennon; Graham Roy Taylor; Arthur Hsu; Jean Marc Pascussi; Frédéric Hollande; Julie Pannequin
Journal:  Gut       Date:  2016-07-25       Impact factor: 23.059

Review 10.  Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.

Authors:  Melinda Szilágyi; Ondrej Pös; Éva Márton; Gergely Buglyó; Beáta Soltész; Judit Keserű; András Penyige; Tomas Szemes; Bálint Nagy
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

View more
  1 in total

Review 1.  Cell Lines of Circulating Tumor Cells: What Is Known and What Needs to Be Resolved.

Authors:  Yutaka Shimada; Tetsuo Sudo; Shusuke Akamatsu; Takuro Sunada; Akira Myomoto; Kiyoshi Okano; Kazuharu Shimizu
Journal:  J Pers Med       Date:  2022-04-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.